Priscilla A. Furth

Concurrent pregnancy retards mammary involution: effects on apoptosis and proliferation of the mammary epithelium after forced weaning of mice.

Low-volume jet injection for intradermal immunization in rabbits.

Loss of Stat5a delays mammary cancer progression in a mouse model.

Conditional over-expression of estrogen receptor alpha in a transgenic mouse model.

The role of prolactin in mammary carcinoma.

Impaired meiotic DNA-damage repair and lack of crossing-over during spermatogenesis in BRCA1 full-length isoform deficient mice.

Chemoprevention of mammary carcinogenesis in a transgenic mouse model by alpha-difluoromethylornithine (DFMO) in the diet is associated with decreased cyclin D1 activity.

Conditional mouse models demonstrate oncogene-dependent differences in tumor maintenance and recurrence.

Introduction of estrogen receptor-alpha into the tTA/TAg conditional mouse model precipitates the development of estrogen-responsive mammary adenocarcinoma.

Loss of protein phosphatase 2A expression correlates with phosphorylation of DP-1 and reversal of dysplasia through differentiation in a conditional mouse model of cancer progression.

Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers.

Early parity significantly elevates mammary tumor incidence in MMTV-c-myc transgenic mice.

Explant-cell culture of primary mammary tumors from MMTV-c-Myc transgenic mice.

Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice.

Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ.

Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer.

PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis.

The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.

Effect of bilateral oophorectomy on mammary tumor formation in BRCA1 mutant mice.

Reflectance confocal microscopy for characterization of mammary ductal structures and development of neoplasia in genetically engineered mouse models of breast cancer.

Regulation of progesterone receptor signaling by BRCA1 in mammary cancer.

Methoxychlor induces atresia of antral follicles in ERalpha-overexpressing mice.

What do shifts in indicators of apoptosis indicate about the cancer process?

Effects of ERalpha overexpression on female reproduction in mice.

BAX is involved in regulating follicular growth, but is dispensable for follicle atresia in adult mouse ovaries.

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.

BAX regulates follicular endowment in mice.

Real-time imaging and characterization of human breast tissue by reflectance confocal microscopy.

Comparison of mouse mammary gland imaging techniques and applications: reflectance confocal microscopy, GFP imaging, and ultrasound.

The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice.

Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis.

Functional mimicry of the acetylated C-terminal tail of p53 by a SUMO-1 acetylated domain, SAD.

Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia.

Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content.

BRCA1 deficient mouse models to study pathogenesis and therapy of triple negative breast cancer.

Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models.

Comparison of increased aromatase versus ERα in the generation of mammary hyperplasia and cancer.

Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer.

The CDK4/6 inhibitor PD0332991 reverses epithelial dysplasia associated with abnormal activation of the cyclin-CDK-Rb pathway.

Cancer prevention as biomodulation: targeting the initiating stimulus and secondary adaptations.